Browsing Tag
Viatris Inc.
2 posts
Viatris launches $1.65bn Pacira tender, but 11-cent share-price gap limits potential upside
Viatris Inc. (NASDAQ: VTRS) has formally launched its $36.50-per-share cash tender offer for Pacira BioSciences, Inc. (NASDAQ: PCRX),…
Theravance Biopharma (NASDAQ: TBPH) drops rare disease drug after Phase 3 failure triggers strategic review
Theravance Biopharma drops its rare disease drug after a Phase 3 failure. Explore what this means for NASDAQ: TBPH and biotech investors.